Increased mitochondrial respiration maintains the mitochondrial membrane potential and promotes survival of cerebellar neurons in an endogenous model of glutamate receptor activation

Journal of Neurochemistry

Volumn 92, Issue 1, 2005, Pages 183-190

  García, Octavio ^a,c   Almeida, Angeles ^b   Massieu, Lourdes ^c   Bolaños, Juan P ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^c INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

Author keywords

Free radicals; Glutamate; Glutathione; Mitochondria; Neurodegeneration; Neuroprotection

Indexed keywords

3 NITROPROPIONIC ACID; DICARBOXYLIC ACID DERIVATIVE; DIZOCILPINE; FREE RADICAL; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; L TRANS PYRROLIDINE 2,4 DICARBOXYLATE; OXIDOREDUCTASE INHIBITOR; REACTIVE OXYGEN METABOLITE; SUCCINATE DEHYDROGENASE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN NERVE CELL; CELL MEMBRANE POTENTIAL; CEREBELLUM; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG INHIBITION; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY CHAIN;

ANIMALS; APOPTOSIS; CELL RESPIRATION; CELL SURVIVAL; CELLS, CULTURED; CEREBELLUM; DICARBOXYLIC ACIDS; INTRACELLULAR MEMBRANES; MEMBRANE POTENTIALS; MITOCHONDRIA; NEURONS; PYRROLIDINES; RATS; RATS, WISTAR; RECEPTORS, GLUTAMATE;

ANIMALIA;

EID: 13244285022     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02851.x     Document Type: Article

References (41)

1. Almeida A. and Bolaños J. P. (2001) A transient inhibition of mitochondrial ATP synthesis by nitric oxide synthase activation triggered apoptosis in primary cortical neurons. J. Neurochem. 77, 676-690.
2. Almeida A., Almeida J., Bolaños J. P. and Moncada S. (2001) Different responses of astrocytes and neurons to nitric oxide, the role of glycolytically generated ATP in astrocyte protection. Proc. Natl Acad. Sci. USA 98, 15 294-15 299.
3. Anderson M. F. and Sims N. R. (1999) Mitochondrial respiratory function and cell death in focal cerebral ischemia. J. Neurochem. 73, 1189-1199.
4. Ankarcrona M., Dypbukt J. M., Bonfoco E., Zhivotovovsky B., Orrenius S., Lipton S. A. and Nicotera P. (1995) Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15, 961-973.
5. Arzberger T., Krampfl K., Leimgruber S. and Weindl A. (1997) Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington's disease. An in situ hybridization study. J. Neuropathol. Exp. Neurol. 56, 440-454.
6. Benveniste H., Drejer J., Schousboe A. and Diemer N. H. (1984) Evaluation of extracellular concentrations of glutamate and aspartate in the rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43, 1369-1374.
7. Bindokas V. P., Jordan J., Lee C. C. and Miller R. J. (1996) Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine. J. Neurosci. 16, 1324-1336.
8. Bittigau P. and Ikonomidou C. (1997) Glutamate in neurological diseases. J. Child Neurol. 12, 471-485.
9. Browne S., Bowling A., MacGarvey U., Baik M., Berger S., Muqit M. and Bird E. (1997) Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann. Neurol. 41, 646-653.
10. Cebers G., Cebere A., Wägner A. and Liljequist S. (1999) Prolonged inhibition of glutamate reuptake down-regulates NMDA receptor functions in cultured cerebellar granule cells. J. Neurochem. 72, 2181-2190.
11. Chen Y. and Swanson R. A. (2003) The glutamate transporters EAAT2 and EAAT3 mediate cysteine uptake in cortical neuron cultures. J. Neurochem. 84, 1332-1339.
12. Dringen R. and Hamprecht B. (1996) Glutathione content as an indicator for the presence of metabolic pathways of amino acids in astroglial cultures. J. Neurochem. 67, 1375-1382.
13. Duchen M. R. (2000) Mitochondrial and calcium: from cell signalling to cell death. J. Physiol. 529, 57-68.
14. Dugan L. L., Sensi S. L., Canzoniero L. M. T., Handran S. D., Rothman S. M., Lin T. S., Goldberg M. P. and Choi D. W. (1995) Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate. J. Neurosci. 15, 6377-6388.
15. Fiskum G., Murphy A.N. and Beal M.F. (1999) Mitochondria in neurodegeneration, acute ischemia and chronic neurodegenerative disease. J. Cereb. Blood Flow Metab. 19, 351-369.
16. Garcia O. and Massieu L. (2001) Strategies for neuroprotection against L-trans-2,4-pyrrolidine dicarboxylate-induced neuronal damage during energy impairment in vitro. J. Neurosci. Res. 64, 418-428.
17. García O. and Massieu L. (2003) Glutamate uptake inhibitor L-trans-pyrrolidine 2,4-dicarboxylate becomes neurotoxic in the presence of subthershold concentrations of mitochondrial toxin 3-nitro-propionate, involvement of mitochondrial reducing activity and ATP production. J. Neurosci. Res. 74, 956-966.
18. García-Nogales P., Almeida A. and Bolaños J. P. (2003) Peroxynitrite protects neurons against nitric oxide-mediated apoptosis. J. Biol. Chem. 278, 864-874.
19. Greene J. and Greenamyre J. (1995) Exacerbation of NMDA, AMPA, and L-glutamate excitotoxicity by the succinate dehydrogenase inhibitor malonate. J. Neurochem. 64, 2332-2338.
20. Gu M., Gash M. T., Mann V. M., Javoy-Agid F., Cooper J. M. and Schapira A. H. V. (1996) Mitochondrial defect in Huntington's disease caudate nucleus. Ann. Neurol. 39, 389-399.
21. Hempel S. L., Buettner G. R., O'Malley Y. Q., Wessels D. A. and Flaherty D. M. (1999) Dihydrofluorescein diacetate is superior for detecting intracellular oxidants, comparison with 2′,7′- dichlorodihydrofluorescein diacetate, 5(and 6)-carboxy-2′,7′- dichlorodihydrofluorescein diacetate, and dihydrorhodamine 123. Free Rad. Biol. Med. 27, 146-159.
22. Himi T., Ikeda M., Yasuhara T., Nishida M. and Morita I. (2003) Role of neuronal glutamate transporter in the cysteine uptake and intracellular glutathione levels in cultured cortical neurons. J. Neural Transm. 110, 1337-1348.
23. Lafón-Cazal M., Pietri S., Culcasi M. and Bockaert J. (1993) NMDA-dependent superoxide production and neurotoxicity. Nature 364, 535-537.
24. Lowry O. H., Rosebrough N. J., Lewis-Farr A. and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
25. Massieu L., Morales-Villagrán A. and Tapia R. (1995) Accumulation of extracellular glutamate by inhibition of its uptake is not sufficient for inducing neuronal damage, an in vivo microdialysis study. J. Neurochem. 64, 2262-2272.
26. Massieu L., Gómez-Román N. and Montiel T. (2000) In vivo potentiation of glutamate-mediated neuronal damage after chronic administration of the glycolysis inhibitor iodoacetate. Exp. Neurol. 165, 257-267.
27. Mitani A. and Tanaka K. (2003) Functional changes of glial glutamate transporter GLT-1 during ischemia, an in vivo study in the hippocampal CA1 of normal mice and mutant mice lacking GLT-1. J. Neurosci. 23, 7176-7182.
28. Nicholls D. G., Vesce S., Kira L. and Chalmers S. (2003) Interactions between mitochondrial bioenergetics and cytoplasmic calcium in cultured cerebellar granule cells. Cell Calcium 34, 407-424.
29. Novelli A., Reilly J. A., Lysko P. G. and Henneberry R. C. (1988) Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res. 451, 205-212.
30. Pang Z. and Geddes J. W. (1997) Mechanism of cell death induced by the mitochondrial toxin 3-nitropropionic acid, acute excitotoxic necrosis and delayed apoptosis. J. Neurosci. 17, 3064-3073.
31. Panov A. V., Gutekunst C.-A., Leavitt B. R., Hayden M. R., Burke J. R., Strittmatter W. J. and Greenamyre J. T. (2002) Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat. Neurosci. 5, 731-736.
32. Peng T. I and Greenamyre T. (1998) Privileged access to mitochondria of calcium influx through N-methyl-D-aspartate receptors. Mol. Pharmacol. 53, 974-980.
33. Ragan C. I., Wilson M. T., Darley-Usmar V. M. and Lowe P. N. (1987) Subfractionation of mitochondria and isolation of the proteins of oxidative phosphorylation, in Mitochondria. A Practical Approach (Darley-Usmar, V. M., Rickwood, D. and Wilson, M. T., eds), pp. 79-112. IRL Press, London.
34. Ré D. B., Boucrat J., Samuel D., Birman S., Kerkerian-Le Goff L. and Had-Aissouni L. (2003) Glutamate transport alteration triggers differentiation-state selective oxidative death of cultured astrocytes: a mechanism different from excitotoxicity depending on intracellular GSH contents. J. Neurochem. 85, 1159-1170.
35. Rossi D. J., Oshima T. and Attwell D. (2000) Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature 403, 316-321.
36. Sánchez-Carbente M. R. and Massieu L. (1999) Transient inhibition of glutamate uptake in vivo induces neurodegeneration when energy metabolism is impaired. J. Neurochem. 72, 129-138.
37. Schinder A. F., Olson E. C., Spitzer N. C. and Montal M. (1996) Mitochondrial dysfunction is a primary even in glutamate neurotoxicity. J. Neurosci. 16, 6125-6133.
38. Tietze F. (1996) Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione, applications to mammalian blood and other tissues. Anal. Biochem. 27, 502-522.
39. Vásquez O. L., Almeida A. and Bolaños J. P. (2001) Depletion of glutathione up-regulates mitochondrial complex I expression in glial cells. J. Neurochem. 76, 1593-1596.
40. White R. J. and Reynolds I. J. (1996) Mitochondrial depolarization in glutamate-stimulated neurons, an early signal specific to excitotoxin exposure. J. Neurosci. 16, 5688-5697.
41. Zeron M. M., Chen N., Moshaver A., Ting-Chun Lee A., Wellington C. L., Hayden M. R. and Raymond L. A. (2001) Mutant huntingtin enhances excitotoxic cell death. Mol. Cell. Neurosci. 17, 41-53.